CA
MMED

Clearstead Advisors’s MiniMed Group Inc MMED Stock Holding History

Clearstead Advisors’s Portfolio MMED Stock Details MMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18K Buy
+79
New +$1.04K ﹤0.01% 2643

Other funds holding MMED

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Clearstead Advisors's MMED Position: Q2 2026 in Review

Clearstead Advisors opened a new position in MiniMed Group Inc (MMED) in Q2 2026: 79 shares worth $1.18K. The stake represents ﹤0.01% of the portfolio and ranks #2643 among its holdings.

98 funds tracked by Wall St. Rank hold MMED as of Q2 2026.

  • Clearstead Advisors held 79 shares of MiniMed Group Inc worth $1.18K as of Q2 2026.
  • MiniMed Group Inc was a new Clearstead Advisors position in Q2 2026.
  • MiniMed Group Inc made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2643 holding.
  • 98 funds tracked by Wall St. Rank held MiniMed Group Inc as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.